Ningbo David Medical Device Co., Ltd. (SHE:300314)
China flag China · Delayed Price · Currency is CNY
14.60
-0.37 (-2.47%)
Nov 13, 2026, 3:04 PM CST

SHE:300314 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
92.1387.0557.26147.6197.3680.21
Depreciation & Amortization
24.2324.2326.7227.3225.5124.55
Other Amortization
5.335.333.560.09--
Loss (Gain) From Sale of Assets
0.390.390.010.23-0.02-0.12
Asset Writedown & Restructuring Costs
0.020.020.531.61-0.881.95
Loss (Gain) From Sale of Investments
-15.31-15.3110.06-11.595.78-15.99
Provision & Write-off of Bad Debts
1.271.270.230.51.22-
Other Operating Activities
-0.387.23.77-4.6-16.172.89
Change in Accounts Receivable
-25.97-25.97-2.03-9.05-5.6-3.14
Change in Inventory
-19-19-31.05-12.27-11.4-35.31
Change in Accounts Payable
23.7423.7426.78-4.0414.66-3.16
Operating Cash Flow
86.7589.2593.87135.2111.5751.48
Operating Cash Flow Growth
-8.34%-4.92%-30.57%21.18%116.72%-62.62%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-31.89-55.03-139.69-40.39-49.78-6.53
Sale of Property, Plant & Equipment
0.370.430.050.590.020.28
Investment in Securities
131.73131.41-130107.5-2.593.5
Other Investing Activities
-108.79-26.347.034.0611.4119.44
Investing Cash Flow
-8.5750.47-262.6171.76-40.85106.69

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Repaid
--3.44-5.02-2.51-4.08-0.47
Lease Payments
-3.44-3.44-5.02-2.51-4.08-0.47
Net Debt Issued (Repaid)
-3.44-3.44-5.02-2.51-4.08-0.47
Common Dividends Paid
-23.04-25.06-51.84-43.2-28.8-43.2
Financing Cash Flow
-26.48-28.5-56.86-45.71-32.88-43.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-19.17-4.87-0.296.3317.05-2.87
Net Cash Flow
32.52106.35-225.9167.5854.89111.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
54.8634.22-45.8294.8161.7944.95
Free Cash Flow Growth
259.98%--53.43%37.48%-60.41%
Free Cash Flow Margin
8.95%5.86%-8.70%15.33%12.21%9.48%
Free Cash Flow Per Share
0.190.12-0.160.330.220.16
Levered Free Cash Flow
31.12-0.69-60.3965.5625.7618.97
Unlevered Free Cash Flow
31.31-0.42-60.0965.9325.9718.99
Free Cash Flow After Leases
51.4230.78-50.8492.357.7144.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
14.7220.8522.1256.9634.8233.17
Change in Working Capital
-20.94-20.94-8.28-25.97-1.23-42.02